The degree of seroprotection against diphtheria in Poland was evaluated by
determination of IgG antibodies to Corynebacterium diphtheriae toxin (IgG-D
TAb). The study population consisted of 4829 healthy subjects aged from 1 d
ay to 85 years from 7 regions of Poland. Serum samples collected between 19
96 and 1998 were assayed for IgG-DTAb antibodies using a toroid enzyme immu
noassay. Neutralization of toxin in Vero cells was performed as a reference
method with the WHO standard for human diphtheria antitoxin. The study rev
ealed a lack of seroprotection (IgG-DTAb < 0.1 IU/mI) in 23 % of individual
s, basic seroprotection (0.1-1.0 IU/ml) in 64 %, and effective seroprotecti
on (> 1.0 IU/ml) in 13 %. The non-protected group consisted of non-vaccinat
ed children below 2 months of age (10%), individuals between 2 months and 1
8 years old (20 %) and greater than 19 years old (70 %). Of the adults, 32
% were seronegative, 63 % had basic seroprotection and only 5 % were fully
protected: 43 % of adults between 30 and 64 years, who had not been vaccina
ted at least during the previous 10 years were not protected against diphth
eria. The geometric mean titre (GMT) of IgG-DTAb was 0.25 IU/ml in the tota
l population. Age-related GMTs differed significantly from each other and w
ere higher (0.44 IU/ml) in individuals from 2 months to 18 years old, compa
red with 0.14 IU/ml and 0.17 IU/ml in children under 2 months and adults, r
espectively. No significant difference was found in the GMTs of men and wom
en in all age groups. We conclude that the currently used vaccination progr
amme in Poland is highly effective and assures protection against diphtheri
a in the majority of the population in the 10-year period following the las
t booster. However, a significant proportion of adults between 30 and 64 ye
ars lack protection and this indicates a need for booster immunization for
this group.